PRKAA1 and type 2 diabetes mellitus: Much of the research conducted about AMPK-mediated effects of myokines on metabolism in a pathophysiological context has been in models of type 2 diabetes, and some research has been conducted with obesity models as obesity is a prime risk factor for diabetes (Schnurr et al., 2020).